entity

FE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about FE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections
30Hypotheses
8Analyses
2Outgoing
0Incoming
7Experiments
8Debates
AI portrait of FE

AI-generated illustration · click image to enlarge

Regenerate portrait ↻

Wiki Pages (20)

Knowledge base pages for this entity

FEEMSA Study: Laryngopharyngeal Function in Neurodegenerative Diseases (NCT04706234)

clinical · 4197 words

Metabolic-Energetic Restoration: GLP-1 + TFEB Activator Combination

idea · 2925 words

Section 244: Advanced Autophagy Induction and TFEB Activation in CBS/PSP

therapeutic · 2683 words

Mitophagy Gate Therapy: PINK1/Parkin + TFEB Priming

idea · 2505 words

TFEB Autophagy Pathway

mechanism · 2374 words

Outgoing (2)

TargetRelationTypeStr
Phospholipid Peroxidationcausesprocess0.95
Substantia Nigraassociated_withbrain_region0.90

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro 0.869 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
miR-155/Interferon-gamma Feedback Loop as a Reversible Molec 0.843 neurodegeneration How do different microglial subtypes (DA
Sequential Iron Chelation (Deferoxamine) and GPX4 Restoratio 0.838 neurodegeneration View
hnRNP A2/B1 Staufen2-Mediated Axonal RNA Granule Transport F 0.834 ALS -
GLE1-Mediated mRNA Export Defect Creates Translation-Compete 0.826 ALS -
SIRT1 Activation Couples Mitochondrial Biogenesis to Ferropt 0.824 neurodegeneration View
MATR3 Nuclear Body Disruption Impairs RNA Processing Hubs an 0.818 ALS -
SLC7A11 System Activation Restores Cystine Uptake and GSH Sy 0.812 neurodegeneration View
Targeting the Mechanistic Link Between AQP4 Dysfunction and 0.803 neurodegeneration View
ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drive 0.801 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Pri 0.801 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
pH-Sensitive Bispecific Antibody Targeting Transferrin Recep 0.800 neurodegeneration Blood-brain barrier antibody transport m
Hypothesis 1: MANF/CDNF Signaling as Primary Neuroprotective 0.798 neurodegeneration View
Closed-loop transcranial focused ultrasound targeting CA1 PV 0.797 Alzheimer's disease Circuit-level neural dynamics in neurode
Targeting SASP-Complement Amplification Through HIF-1α Downs 0.793 neurodegeneration What molecular mechanism causes VCP muta
LAMP2A Liquid-Liquid Phase Separation Defects in Dopaminergi 0.783 neurodegeneration -
Differential Complement Regulator Expression on Synaptic Mem 0.783 synaptic biology What determines the selectivity of compl
TFEB Nuclear Translocation to Reset Lysosomal-Hypoxia Axis 0.779 neurodegeneration What molecular mechanism causes VCP muta
ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligo 0.779 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferrop 0.777 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Sub 0.776 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes v 0.772 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vul 0.764 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
Iron-driven lipid peroxidation and GPX4 failure create a fer 0.750 neurodegeneration What mechanisms drive the self-amplifyin
GBA1 Loss Triggers a TFEB-to-TFE3 Compensatory Switch in A9 0.750 neurodegeneration -
GPX4 reserve failure gates selective ALS motor-neuron ferrop 0.745 neurodegeneration Ferroptosis in ALS motor neuron vulnerab
Seed-Proximal Asymmetric Duplex Stability Confers lncRNA-002 0.733 molecular neurobiology View
Endosomal trafficking defects are the common upstream lesion 0.730 neurodegeneration What determines the temporal sequence of
TFEB/TFE3 Parallel Activation Drives Coordinated Organelle C 0.727 neurodegeneration How do different organelle-specific auto
Calcium-Dependent S100B Release from Astrocyte End-Feet as a 0.725 - What blood-brain barrier permeability ch

Mentioning Analyses (8)

Scientific analyses that reference this entity

Why does iron chelation therapy worsen outcomes in H63D HFE variant carriers des

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.586

What validated biomarkers can determine optimal TFEB activity windows during dis

neurodegeneration | 2026-04-11 | 0 hypotheses

Does TFEB activation directly restore mutant GBA enzyme activity or only enhance

molecular biology | 2026-04-11 | 0 hypotheses

Does TFEB dysfunction causally drive neurodegeneration or represent compensatory

molecular biology | 2026-04-10 | 0 hypotheses

Why do structurally diverse sugars (trehalose, melibiose, lactulose) produce ide

neurodegeneration | 2026-04-08 | 3 hypotheses Top: 0.470

Experiments (7)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
SAHA@LIPO-ANG2 therapeutic efficacy in 5xFAD mice validation Alzheimer's disease 0.900 0.00 5xFAD transgenic mice proposed N/A
Transcriptomic profiling and differential expression analysis exploratory Alzheimer's disease 0.900 0.00 1-month-old APP/PS1 mice cereb proposed N/A
Irisin effects on osteogenic differentiation in mesenchymal stem cells exploratory bone fracture 0.900 0.00 mouse bone mesenchymal stem ce proposed N/A
SIRPα modulation in mouse models of Alzheimer's disease validation Alzheimer's disease 0.900 0.00 mouse models of Alzheimer's di proposed N/A
Microglial SIRPα expression in human Alzheimer's disease tissue exploratory Alzheimer's disease 0.800 0.00 human brain tissue proposed N/A
Anti-miR-155 LNA Oligonucleotide Shifts Microglia to Homeostatic State in_vivo neurodegeneration 0.774 0.65 C57BL/6J LPS model (chronic i. proposed $58,000
Sequential DFO + Sulforaphane Prevents Iron-Ferroptosis Cascade in Rat in_vivo post-cardiac-arrest neurodegen 0.768 0.72 Sprague-Dawley rat asphyxial c abandoned $48,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Transcriptomic cytoarchitecture reveals principles of human neocortex organizati [PMID:37824655] Jorstad NL, Close J, Johansen N, Yanny A Science 2023 186
FAK/SRC-JNK axis promotes ferroptosis via upregulating ACSL4 expression. [PMID:41862445] Qin J, Ma S, Wang J, Huang S, Luan J, He Cell death & disease 2026 0
Quercetin attenuates ox-LDL-induced endothelial injury by regulating ferroptosis [PMID:41902795] Gao C, Liu B, Zhang R, Tian J, Xin H Toxicology mechanisms and meth 2026 0
Changes in Circulating Levels of miR-30b During Minipuberty and Puberty in Girls [PMID:40899010] Albrechtsen HM, Saritas G, Winge SB, Mai J Clin Endocrinol Metab 2026 0
Epigenetics in chronic rhinosinusitis. [PMID:41442742] Kumar N, Brar T, Lal D Curr Opin Otolaryngol Head Nec 2026 0
NEDD8 promotes the ferritinophagy and ferroptosis of neurons in ischemic stroke [PMID:41662890] Rao W, Huang Y, Li J, Chen Q, Sun J et a J Stroke Cerebrovasc Dis 2026 0
Inhibition of Ferroptosis in Prostatitis Model by Low Intensity Extracorporeal S [PMID:41714892] Lin D, Li K, Kuang W, Chen Z, Zhang M World J Mens Health 2026 0
Deciphering sorafenib resistance in hepatocellular carcinoma via ferroptotic mec [PMID:41763496] Che L, Zhu L, Zhou L, Zhou Y Biochim Biophys Acta Rev Cance 2026 0
ACSL4-mediated astrocyte ferroptosis augments neuroinflammation and exacerbates [PMID:41776085] Wen H, Zi Y, Liu Z, Bai Y, Lin J et al. Cell Death Differ 2026 0
Extracellular vesicles in type 2 diabetes exhibit elevated miR-155 cargo and Ann [PMID:41786286] Jackson G, Islam H, de Souza Teixeira AA Life Sci 2026 0
B4GALT1 deficiency attenuates steatohepatitis by regulating the PPARγ/ACSL4 axis [PMID:41860570] Chien Y, Xia R, Zhou D, Ai Y, Wu L et al Hepatol Commun 2026 0
Decoding microRNA-Protein Interaction Networks in Alzheimer's Disease: Molecular [PMID:41918207] Mishra R, Gupta JK Curr Alzheimer Res 2026 0
Multimodal MR Imaging Reveals the Mechanisms of Post-Cardiac-Arrest Brain edema: [PMID:41933462] Tan Y, Ye H, Ge Q, Wang P, Liu Z et al. J Magn Reson Imaging 2026 0
Di-2-ethylhexylphthalate-induced miR155-5P promotes placental ferroptosis. [PMID:41937013] Gu X, Sun F, Li Y, Yang S, Li Y Int J Biol Macromol 2026 0
Extracellular Vesicles in Obesity: From Pathophysiological Mediators to Therapeu [PMID:41977323] Pavlović N, Todorović P, Maglica M, Kopi Int J Mol Sci 2026 0
Unraveling the impact of risk factors on the ferroptosis-Alzheimer's disease lin [PMID:41498558] Singh P, Rath SL Journal of Alzheimer's disease 2026 0
Resveratrol Alleviates Intervertebral Disc Degeneration by Targeting NCOA4-Media [PMID:41873334] Song C, Wu X, Chen C, Shen B, He Y, Liu Drug design, development and t 2026 0
Pan-PPAR agonist bezafibrate alleviates psoriasis by suppressing LCN2-dependent [PMID:41662914] ["Xin R", "Zhang J", "Zhang Y", "Dai M", Free radical biology & medicin 2026 0
Acteoside alleviates sepsis-induced acute lung injury by activating the Nrf2 pat [PMID:41895086] Wang Y, Zhang W, Zhang M, Zhu Y, Wang W, Tissue & cell 2026 0
Decoding microRNA-Protein Interaction Networks in Alzheimer's Disease: Molecular [PMID:41918207] Mishra R, Gupta JK Current Alzheimer research 2026 0

Debates (8)

Multi-agent debates referencing this entity

The study shows trehalose causes lysosomal membrane permeabilization (LMP) that

closed · Rounds: 4 · Score: 0.61 · 2026-04-21

While the study establishes that trehalose-induced lysosomal permeabilization ac

closed · Rounds: 4 · Score: 0.73 · 2026-04-21

The finding that trehalase-resistant analogs and other disaccharides mimic treha

closed · Rounds: 4 · Score: 0.60 · 2026-04-21

The debate identified this as a critical mechanistic gap - TFEB may increase lys

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

The core causation versus correlation debate remains unresolved despite being ce

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

The debate proposed temporal TFEB modulation but identified no validated biomark

closed · Rounds: 4 · Score: 1.00 · 2026-04-20

The study shows deferiprone rescues wild-type cells but exacerbates toxicity in

closed · Rounds: 4 · Score: 0.95 · 2026-04-15

The debate highlighted TFEB's role in mitochondrial-lysosomal coupling but could

closed · Rounds: 4 · Score: 0.95 · 2026-04-03

Related Research

Hypotheses and analyses mentioning FE in their description or question text

SIRT1 Activation Couples Mitochondrial Biogenesis to Ferroptosis Suppression via

Score: 0.824 · neurodegeneration · 2026-04-17

## Mechanistic Overview SIRT1 Activation Couples Mitochondrial Biogenesis to Ferroptosis Suppression via PGC1alpha-Depen

SLC7A11 System Activation Restores Cystine Uptake and GSH Synthesis to Prevent N

Score: 0.812 · neurodegeneration · 2026-04-17

## Mechanistic Overview SLC7A11 System Activation Restores Cystine Uptake and GSH Synthesis to Prevent Neuronal and Endo

Targeting the Mechanistic Link Between AQP4 Dysfunction and Ferroptosis Prevents

Score: 0.803 · neurodegeneration · 2026-04-17

## Mechanistic Overview Targeting the Mechanistic Link Between AQP4 Dysfunction and Ferroptosis Prevents Both Cytotoxic

ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matter Degen

Score: 0.801 · Alzheimer's Disease · 2026-04-05

## Mechanistic Overview ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matter Degeneration in Alzhe

40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Selectively

Score: 0.801 · Alzheimer's Disease · 2026-04-05

## Mechanistic Overview 40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Selectively Eliminate Diseas

pH-Sensitive Bispecific Antibody Targeting Transferrin Receptor for CNS Delivery

Score: 0.800 · neurodegeneration · 2026-04-22

## Mechanistic Overview pH-Sensitive Bispecific Antibody Targeting Transferrin Receptor for CNS Delivery starts from the

Hypothesis 1: MANF/CDNF Signaling as Primary Neuroprotective Effector

Score: 0.798 · neurodegeneration · 2026-04-17

## Mechanistic Overview Hypothesis 1: MANF/CDNF Signaling as Primary Neuroprotective Effector starts from the claim that

Closed-loop transcranial focused ultrasound targeting CA1 PV interneurons with r

Score: 0.797 · Alzheimer's disease · 2026-04-07

## Mechanistic Overview Closed-loop transcranial focused ultrasound targeting CA1 PV interneurons with real-time gamma f

Targeting SASP-Complement Amplification Through HIF-1α Downstream Effectors

Score: 0.793 · neurodegeneration · 2026-04-14

## Mechanistic Overview Targeting SASP-Complement Amplification Through HIF-1α Downstream Effectors starts from the clai

Differential Complement Regulator Expression on Synaptic Membranes (CD55/CD46)

Score: 0.783 · synaptic biology · 2026-04-21

**Molecular Mechanism and Rationale** The differential expression of complement regulators CD55 (decay-accelerating fac

TFEB Nuclear Translocation to Reset Lysosomal-Hypoxia Axis

Score: 0.779 · neurodegeneration · 2026-04-14

## Mechanistic Overview TFEB Nuclear Translocation to Reset Lysosomal-Hypoxia Axis starts from the claim that modulating

ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligodendrocytes Underlie

Score: 0.779 · Alzheimer's Disease · 2026-04-05

## Mechanistic Overview ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligodendrocytes Underlies White Matter D

LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferroptotic Priming Engine

Score: 0.777 · Alzheimer's Disease · 2026-04-05

## Mechanistic Overview LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferroptotic Priming Engine in Disease-Asso